Spermatech AS

Spermatech AS is a drug discovery company with roots from the University of Oslo (UiO), Norway. Spermatech’s main goals are to develop sperm cell activators to improve animal fertility and to develop a non-hormonal male contraceptive pill for humans.

Spermatech’s compounds can manipulate sperm movement to improve fertility in animals and inhibit fertility in humans by using a key energy mechanism for maintaining sperm motility.

Spermatech has developed a unique assay using live sperm cells which is compatible with High Throughput Screening (HTS). Spermatech’s assay has been used on more than 300 000 compounds to identify male fertilization activators and blockers, this was done in collaboration with the drug discovery company Evotec AG the The Norwegian Biotech Center.

Spermatech is working on two pipelines based on its unique assay: sperm cell activators (animal breeding) and fertility modulators (male contraceptives).